Works matching AU Ryu, Min-Hee

Results: 139
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13

    Role of the prognostic nutritional index in predicting survival in advanced hepatocellular carcinoma treated with regorafenib.

    Published in:
    Hepatology Research, 2021, v. 51, n. 7, p. 796, doi. 10.1111/hepr.13669
    By:
    • Rimini, Margherita;
    • Yoo, Changoon;
    • Lonardi, Sara;
    • Masi, Gianluca;
    • Piscaglia, Fabio;
    • Kim, Hyung‐Don;
    • Rizzato, Mario D.;
    • Salani, Francesca;
    • Ielasi, Luca;
    • Forgione, Antonella;
    • Bang, Yeonghak;
    • Soldà, Caterina;
    • Catanese, Silvia;
    • Sansone, Vito;
    • Ryu, Min‐Hee;
    • Ryoo, Baek‐Yeol;
    • Burgio, Valentina;
    • Cucchetti, Alessandro;
    • Cascinu, Stefano;
    • Casadei‐Gardini, Andrea
    Publication type:
    Article
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36

    Ramucirumab plus paclitaxel as second-line treatment in patients with advanced gastric or gastroesophageal junction adenocarcinoma: a nationwide real-world outcomes in Korea study (KCSG-ST19-16).

    Published in:
    Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211042812
    By:
    • Han, Hye Sook;
    • Kim, Bum Jun;
    • Jee, Hee-Jung;
    • Ryu, Min-Hee;
    • Park, Se Hoon;
    • Rha, Sun Young;
    • Kim, Jong Gwang;
    • Bae, Woo Kyun;
    • Lee, Keun-Wook;
    • Oh, Do-Youn;
    • Kim, In-Ho;
    • Sym, Sun Jin;
    • Oh, So Yeon;
    • Kim, Hyeong Su;
    • Byun, Ji-Hye;
    • Kim, Dong Sook;
    • Suh, Young Ju;
    • An, Hyonggin;
    • Zang, Dae Young
    Publication type:
    Article
    37

    Phase II study of neoadjuvant imatinib in large gastrointestinal stromal tumours of the stomach.

    Published in:
    British Journal of Cancer, 2017, v. 117, n. 1, p. 25, doi. 10.1038/bjc.2017.144
    By:
    • Kurokawa, Yukinori;
    • Yang, Han-Kwang;
    • Cho, Haruhiko;
    • Ryu, Min-Hee;
    • Masuzawa, Toru;
    • Park, Sook Ryun;
    • Matsumoto, Sohei;
    • Lee, Hyuk-Joon;
    • Honda, Hiroshi;
    • Kwon, Oh Kyoung;
    • Ishikawa, Takashi;
    • Lee, Kyung Hee;
    • Nabeshima, Kazuhito;
    • Kong, Seong-Ho;
    • Shimokawa, Toshio;
    • Yook, Jeong-Hwan;
    • Doki, Yuichiro;
    • Im, Seock-Ah;
    • Hirota, Seiichi;
    • Hahn, Seokyung
    Publication type:
    Article
    38
    39
    40
    41

    Data collection framework for electronic medical record-based real-world data to evaluate the effectiveness and safety of cancer drugs: a nationwide real-world study of the Korean Cancer Study Group.

    Published in:
    Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359221132628
    By:
    • Han, Hye Sook;
    • Lee, Kyoung Eun;
    • Suh, Young Ju;
    • Jee, Hee-Jung;
    • Kim, Bum Jun;
    • Kim, Hyeong Su;
    • Lee, Keun-Wook;
    • Ryu, Min-Hee;
    • Baek, Sun Kyung;
    • Park, In Hae;
    • Ahn, Hee Kyung;
    • Jeong, Jae Ho;
    • Kim, Min Hwan;
    • Lee, Dae Hyung;
    • Kim, Siheon;
    • Moon, Hyemi;
    • Son, Serim;
    • Byun, Ji-Hye;
    • Kim, Dong Sook;
    • An, Hyonggin
    Publication type:
    Article
    42

    Real-world efficacy and safety of cabozantinib in Korean patients with advanced hepatocellular carcinoma: a multicenter retrospective analysis.

    Published in:
    Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359221097934
    By:
    • Bang, Yeong Hak;
    • Lee, Choong-kun;
    • Yoo, Changhoon;
    • Chon, Hong Jae;
    • Hong, Moonki;
    • Kang, Beodeul;
    • Kim, Hyung-Don;
    • Park, Sook Ryun;
    • Choi, Won-Mook;
    • Choi, Jonggi;
    • Lee, Danbi;
    • Shim, Ju Hyun;
    • Kim, Kang Mo;
    • Lim, Young-Suk;
    • Lee, Han Chu;
    • Ryu, Min-Hee;
    • Ryoo, Baek-Yeol
    Publication type:
    Article
    43

    Ramucirumab plus paclitaxel as second-line treatment in patients with advanced gastric or gastroesophageal junction adenocarcinoma: a nationwide real-world outcomes in Korea study (KCSG-ST19-16).

    Published in:
    Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211042812
    By:
    • Han, Hye Sook;
    • Kim, Bum Jun;
    • Jee, Hee-Jung;
    • Ryu, Min-Hee;
    • Park, Se Hoon;
    • Rha, Sun Young;
    • Kim, Jong Gwang;
    • Bae, Woo Kyun;
    • Lee, Keun-Wook;
    • Oh, Do-Youn;
    • Kim, In-Ho;
    • Sym, Sun Jin;
    • Oh, So Yeon;
    • Kim, Hyeong Su;
    • Byun, Ji-Hye;
    • Kim, Dong Sook;
    • Suh, Young Ju;
    • An, Hyonggin;
    • Zang, Dae Young
    Publication type:
    Article
    44
    45
    46
    47
    48
    49
    50

    Biomarker and pharmacodynamic activity of the transforming growth factor‐beta (TGFβ) inhibitor SAR439459 as monotherapy and in combination with cemiplimab in a phase I clinical study in patients with advanced solid tumors.

    Published in:
    CTS: Clinical & Translational Science, 2024, v. 17, n. 2, p. 1, doi. 10.1111/cts.13736
    By:
    • Robbrecht, Debbie;
    • Grob, Jean‐Jacques;
    • Bechter, Oliver;
    • Simonelli, Matteo;
    • Doger, Bernard;
    • Borbath, Ivan;
    • Butler, Marcus O.;
    • Cheng, Tina;
    • Romano, Patricia Martin;
    • Pons‐Tostivint, Elvire;
    • Di Nicola, Massimo;
    • Curigliano, Giuseppe;
    • Ryu, Min‐Hee;
    • Rodriguez‐Vida, Alejo;
    • Schadendorf, Dirk;
    • Garralda, Elena;
    • Abbadessa, Giovanni;
    • Demers, Brigitte;
    • Amrate, Amele;
    • Wang, Hong
    Publication type:
    Article